Suicidal Ideation Across Pregnancy and the Postpartum: Recognizing Patterns Across Two Common Screening Tools
A study tracking suicidal ideation across pregnancy and postpartum identified distinct trajectories and differences between the EPDS and PHQ-9, highlighting challenges in screening.
ABCL635 Shows Promise for Menopausal Hot Flashes in Phase 2 Trial
A new nonhormonal treatment targeting the neurokinin 3 receptor significantly reduced the frequency and severity of menopausal hot flashes in a Phase 2 trial.
ADHD Medications During Pregnancy: What Does the Latest Meta-Analysis Tell Us?
A new meta-analysis examines ADHD medication use during pregnancy, finding reassuring results for most outcomes while identifying a possible small increase in cardiovascular malformations with methylphenidate.
Essential Reads: Melatonin and Pregnancy (Clinical Update 2026)
Melatonin is widely used as a sleep aid, but what do we know about its safety during pregnancy? Explore the evidence, potential risks, and treatment options.
A Psychedelic Treatment for Postpartum Depression? Early Findings on GH001
A small phase 2a trial of GH001, an investigational psychedelic compound, found a rapid reduction in postpartum depression symptoms. Larger studies are needed to assess safety and durability.
Essential Reads: How to Screen for Obsessive-Compulsive Symptoms in Postpartum Women?
Perinatal OCD is common but often missed by depression-only screens. Adding perinatal-specific anxiety and OCD tools can improve detection and guide targeted treatment.